BeamOne announces its newest electron beam medical device sterilization service center

NewsGuard 100/100 Score

BeamOne LLC announces that it will locate its newest electron beam medical device sterilization service center in the Pittsburgh, Pennsylvania area. Ground breaking will begin on the new facility in Q4 2009, and it is anticipated to be operational during Q4 2010. Pittsburgh will join the company's successful locations in California, Colorado, Ohio, and Costa Rica.

According to Glenn Thibault, President and CEO of BeamOne, "Our ability to add a fifth facility, following so closely after the January 2009 opening of our Costa Rica service center, emphasizes that electron beam is the sterilization modality choice of the future. The addition of our Pittsburgh center is one more stepping stone on BeamOne's course of controlled expansion and growth."

BeamOne's technological ability to efficiently process virtually any shipment size, as well as accommodate both large and small product configurations, provides medical product manufacturers with processing flexibility and faster time to market. The Pittsburgh build plan includes the opportunity to add a second electron beam system, thus doubling the capacity of the service center to meet customer demand. The new center will provide sterilization services for single-use medical device, pharmaceutical, and labware manufacturers as well as tissue processors.

SOURCE BeamOne LLC

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Decoding the twist: Coronavirus spike proteins reveal their intricate invasion dance